• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年澳大利亚人有无肺炎球菌病风险因素的住院率和病死率:对疫苗政策的影响。

Pneumonia hospitalisation and case-fatality rates in older Australians with and without risk factors for pneumococcal disease: implications for vaccine policy.

机构信息

School of Public Health and Community Medicine, University of New South Wales,Sydney, NSW,Australia.

National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases (NCIRS), Kids Research Institute, Children's Hospital at Westmead,NSW,Australia.

出版信息

Epidemiol Infect. 2019 Jan;147:e118. doi: 10.1017/S0950268818003473.

DOI:10.1017/S0950268818003473
PMID:30869015
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6518507/
Abstract

Community-acquired pneumonia (CAP) results in substantial numbers of hospitalisations and deaths in older adults. There are known lifestyle and medical risk factors for pneumococcal disease but the magnitude of the additional risk is not well quantified in Australia. We used a large population-based prospective cohort study of older adults in the state of New South Wales (45 and Up Study) linked to cause-specific hospitalisations, disease notifications and death registrations from 2006 to 2015. We estimated the age-specific incidence of CAP hospitalisation (ICD-10 J12-18), invasive pneumococcal disease (IPD) notification and presumptive non-invasive pneumococcal CAP hospitalisation (J13 + J18.1, excluding IPD), comparing those with at least one risk factor to those with no risk factors. The hospitalised case-fatality rate (CFR) included deaths in a 30-day window after hospitalisation. Among 266 951 participants followed for 1 850 000 person-years there were 8747 first hospitalisations for CAP, 157 IPD notifications and 305 non-invasive pneumococcal CAP hospitalisations. In persons 65-84 years, 54.7% had at least one identified risk factor, increasing to 57.0% in those ⩾85 years. The incidence of CAP hospitalisation in those ⩾65 years with at least one risk factor was twofold higher than in those without risk factors, 1091/100 000 (95% confidence interval (CI) 1060-1122) compared with 522/100 000 (95% CI 501-545) and IPD in equivalent groups was almost threefold higher (18.40/100 000 (95% CI 14.61-22.87) vs. 6.82/100 000 (95% CI 4.56-9.79)). The CFR increased with age but there were limited difference by risk status, except in those aged 45 to 64 years. Adults ⩾65 years with at least one risk factor have much higher rates of CAP and IPD suggesting that additional risk factor-based vaccination strategies may be cost-effective.

摘要

社区获得性肺炎(CAP)会导致大量老年人住院和死亡。已知存在与肺炎球菌病相关的生活方式和医疗风险因素,但在澳大利亚,其额外风险的严重程度尚未得到充分量化。我们利用新南威尔士州(45 岁及以上研究)中的一项大型基于人群的老年前瞻性队列研究,该研究与 2006 年至 2015 年期间的特定病因住院、疾病报告和死亡登记相关联。我们估计了 CAP 住院(ICD-10 J12-18)、侵袭性肺炎球菌病(IPD)报告和疑似非侵袭性肺炎球菌 CAP 住院(J13 + J18.1,不包括 IPD)的特定年龄发病率,将至少有一个风险因素的人与没有风险因素的人进行了比较。住院病死率(CFR)包括住院后 30 天内的死亡。在 266951 名随访 185 万个人年的参与者中,有 8747 人首次因 CAP 住院,157 人发生 IPD 报告,305 人发生非侵袭性肺炎球菌 CAP 住院。在 65-84 岁的人群中,54.7%至少有一个确定的风险因素,在年龄 ⩾85 岁的人群中增加到 57.0%。在至少有一个风险因素的 ⩾65 岁人群中,CAP 住院的发病率是没有风险因素人群的两倍,前者为 1091/100000(95%置信区间 [CI]1060-1122),后者为 522/100000(95%CI501-545),而在同等人群中,IPD 几乎高三倍(18.40/100000(95%CI14.61-22.87)比 6.82/100000(95%CI4.56-9.79))。CFR 随年龄增长而增加,但风险状况的差异有限,除了 45 至 64 岁的人群。至少有一个风险因素的 ⩾65 岁成年人 CAP 和 IPD 的发病率要高得多,这表明基于额外风险因素的疫苗接种策略可能具有成本效益。

相似文献

1
Pneumonia hospitalisation and case-fatality rates in older Australians with and without risk factors for pneumococcal disease: implications for vaccine policy.老年澳大利亚人有无肺炎球菌病风险因素的住院率和病死率:对疫苗政策的影响。
Epidemiol Infect. 2019 Jan;147:e118. doi: 10.1017/S0950268818003473.
2
Effect of the PCV 10 vaccination on community-acquired pneumonia hospitalisations after four years of its introduction into the Polish National Immunisation Programme: Follow-up study.PCV10 疫苗纳入波兰国家免疫规划 4 年后对社区获得性肺炎住院的影响:随访研究。
Vaccine. 2024 May 10;42(13):3257-3262. doi: 10.1016/j.vaccine.2024.04.019. Epub 2024 Apr 18.
3
Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against community-acquired pneumonia in the general population aged ≥ 60 years: 3 years of follow-up in the CAPAMIS study.23 价肺炎球菌多糖疫苗对 60 岁以上普通人群社区获得性肺炎的有效性:CAPAMIS 研究 3 年随访结果。
Clin Infect Dis. 2014 Apr;58(7):909-17. doi: 10.1093/cid/ciu002. Epub 2014 Feb 13.
4
Incidence and case fatality rates of community-acquired pneumonia and pneumococcal diseases among Korean adults: Catchment population-based analysis.韩国成年人社区获得性肺炎和肺炎球菌病的发病率和病死率:基于人群的集水区分析。
PLoS One. 2018 Mar 29;13(3):e0194598. doi: 10.1371/journal.pone.0194598. eCollection 2018.
5
Monitoring of community-acquired pneumonia hospitalisations before the introduction of pneumococcal conjugate vaccine into Polish National Immunisation Programme (2009-2016): A nationwide retrospective database analysis.监测波兰国家免疫规划引入肺炎球菌结合疫苗前社区获得性肺炎住院情况(2009-2016 年):一项全国性回顾性数据库分析。
Vaccine. 2020 Jan 10;38(2):194-201. doi: 10.1016/j.vaccine.2019.10.031. Epub 2019 Oct 22.
6
The burden of hospitalisations for community-acquired pneumonia (CAP) and pneumococcal pneumonia in adults in Spain (2003-2007).西班牙成年人社区获得性肺炎(CAP)和肺炎球菌性肺炎住院负担(2003-2007 年)。
Vaccine. 2011 Jan 10;29(3):412-6. doi: 10.1016/j.vaccine.2010.11.025. Epub 2010 Nov 25.
7
Age-stratified burden of pneumococcal community acquired pneumonia in hospitalised Canadian adults from 2010 to 2015.2010 年至 2015 年加拿大住院成年患者中肺炎球菌性社区获得性肺炎的年龄分层负担。
BMJ Open Respir Res. 2020 Mar;7(1). doi: 10.1136/bmjresp-2019-000550.
8
Predictors of pneumococcal vaccination among older adults with pneumonia: findings from the Community Acquired Pneumonia Impact Study.肺炎老年患者中肺炎球菌疫苗接种的预测因素:社区获得性肺炎影响研究的结果。
BMC Geriatr. 2010 Jun 30;10:44. doi: 10.1186/1471-2318-10-44.
9
Pneumonia hospitalisations in Scotland following the introduction of pneumococcal conjugate vaccination in young children.在幼儿中引入肺炎球菌结合疫苗后,苏格兰的肺炎住院情况。
BMC Infect Dis. 2016 Aug 9;16:390. doi: 10.1186/s12879-016-1693-x.
10
Burden of pneumococcal community-acquired pneumonia in adults across Europe: A literature review.欧洲成年人社区获得性肺炎的负担:文献综述。
Respir Med. 2018 Apr;137:6-13. doi: 10.1016/j.rmed.2018.02.007. Epub 2018 Feb 19.

引用本文的文献

1
Semi-purified Antimicrobial Proteins from Oyster Hemolymph Inhibit Pneumococcal Infection.牡蛎血淋巴半纯化抗菌蛋白抑制肺炎球菌感染。
Mar Biotechnol (NY). 2024 Oct;26(5):862-875. doi: 10.1007/s10126-024-10297-w. Epub 2024 Mar 2.
2
Increased Risk of Hospitalization for Pneumonia in Italian Adults from 2010 to 2019: Scientific Evidence for a Call to Action.2010年至2019年意大利成年人肺炎住院风险增加:行动呼吁的科学依据
Vaccines (Basel). 2023 Jan 16;11(1):187. doi: 10.3390/vaccines11010187.
3
Vaccines and Senior Travellers.疫苗与老年旅行者

本文引用的文献

1
Determining the contribution of <em>Streptococcus pneumoniae</em> to community-acquired pneumonia in Australia.确定 <em>肺炎链球菌</em> 对澳大利亚社区获得性肺炎的贡献。
Med J Aust. 2017 Nov 6;207(9):396-400. doi: 10.5694/mja16.01102.
2
Hospitalization costs for community-acquired pneumonia in Dutch elderly: an observational study.荷兰老年人社区获得性肺炎的住院费用:一项观察性研究。
BMC Infect Dis. 2016 Sep 2;16(1):466. doi: 10.1186/s12879-016-1783-9.
3
Rates of pneumonia among children and adults with chronic medical conditions in Germany.
Front Aging. 2021 Jul 9;2:677907. doi: 10.3389/fragi.2021.677907. eCollection 2021.
4
Immune age and biological age as determinants of vaccine responsiveness among elderly populations: the Human Immunomics Initiative research program.免疫年龄和生物年龄作为老年人群疫苗反应性的决定因素:人类免疫组学倡议研究计划。
Eur J Epidemiol. 2021 Jul;36(7):753-762. doi: 10.1007/s10654-021-00767-z. Epub 2021 Jun 12.
德国患有慢性疾病的儿童和成人的肺炎发病率。
BMC Infect Dis. 2015 Oct 30;15:470. doi: 10.1186/s12879-015-1162-y.
4
Pneumonia in Elderly Australians: Reduction in Presumptive Pneumococcal Hospitalizations but No Change in All-Cause Pneumonia Hospitalizations Following 7-Valent Pneumococcal Conjugate Vaccination.澳大利亚老年人肺炎:7 价肺炎球菌结合疫苗接种后疑似肺炎球菌住院人数减少,但各种原因导致的肺炎住院人数无变化。
Clin Infect Dis. 2015 Sep 15;61(6):927-33. doi: 10.1093/cid/civ429. Epub 2015 Jun 11.
5
Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults.多糖结合疫苗预防成人肺炎球菌性肺炎。
N Engl J Med. 2015 Mar 19;372(12):1114-25. doi: 10.1056/NEJMoa1408544.
6
Rates of pneumococcal disease in adults with chronic medical conditions.慢性基础疾病成人的肺炎球菌病发病率。
Open Forum Infect Dis. 2014 May 27;1(1):ofu024. doi: 10.1093/ofid/ofu024. eCollection 2014 Mar.
7
Risk factors for community-acquired pneumonia in adults in Europe: a literature review.欧洲成人社区获得性肺炎的危险因素:文献综述。
Thorax. 2013 Nov;68(11):1057-65. doi: 10.1136/thoraxjnl-2013-204282.
8
National Hospital Discharge Survey: 2007 summary.国家医院出院调查:2007年总结
Natl Health Stat Report. 2010 Oct 26(29):1-20, 24.
9
Management of community-acquired pneumonia: a review and update.社区获得性肺炎的管理:综述与更新。
Ther Adv Respir Dis. 2011 Feb;5(1):61-78. doi: 10.1177/1753465810381518. Epub 2010 Oct 8.
10
Community-acquired pneumonia in elderly patients.老年患者社区获得性肺炎
Aging health. 2009;5(6):763-774. doi: 10.2217/ahe.09.74.